Drizalma Sprinkle | Duloxetine Capsule, Delayed Release while Breastfeeding
What is Drizalma Sprinkle | Duloxetine Capsule, Delayed Release used for?
Is Drizalma Sprinkle | Duloxetine Capsule, Delayed Release safe to use while breastfeeding? Can it interfere with growth and development of my kid?
Drizalma Sprinkle | Duloxetine Capsule, Delayed Release Breastfeeding Analsys
Duloxetine while Breastfeeding
SafeCAS Number: 116539-59-4
It is a reuptake-inhibitor of Serotonin and Norepinephrine. Excreted into breast milk in clinically non-significant amount with no side-effects being observed in breastfed infants from treated mothers. Plasma level in those infants was very low or undetectable. Because there is less experience published than with other antidepressants of the same pharmacological group, it should be preferred the use of an alternative drug that is known to be safer in the neonatal period or prematurity. Galactorrhea has been observed but less frequently than with other antidepressants. Women who use antidepressant medication during pregnancy are in need of more support for breastfeeding since they are at risk for early weaning.
Drizalma Sprinkle | Duloxetine Capsule, Delayed Release Breastfeeding Analsys - 2
Duloxetine while Breastfeeding
CAS Number: 116539-58-3
Little published information is available on the use of duloxetine during breastfeeding; however, the dose in milk is low and serum levels were low in two breastfed infants. An alternate drug that has been better studied may be preferred, especially while nursing a newborn or preterm infant. If duloxetine is required by the mother, it is not a reason to discontinue breastfeeding. Monitor the infant for drowsiness, adequate weight gain, and developmental milestones, especially in younger, exclusively breastfed infants and when using combinations of psychotropic drugs. Galactorrhea has been reported in women taking duloxetine.
What should I do if already breastfed my kid after using Drizalma Sprinkle | Duloxetine Capsule, Delayed Release?
As usage of Drizalma Sprinkle | Duloxetine Capsule, Delayed Release is mostly safe while breastfeeding hence there should not be any concern. In case of any change in behavior or health of your baby you should inform your health care provider about usage of Drizalma Sprinkle | Duloxetine Capsule, Delayed Release else no further action is required.
My health care provider has asked me to use Drizalma Sprinkle | Duloxetine Capsule, Delayed Release, what to do?
Definitely, Drizalma Sprinkle | Duloxetine Capsule, Delayed Release is safe in lactation for baby. No wonder your doctor has recommended it.
If I am using Drizalma Sprinkle | Duloxetine Capsule, Delayed Release, will my baby need extra monitoring?
No extra baby monitoring required while mother is using Drizalma Sprinkle | Duloxetine Capsule, Delayed Release
Who can I talk to if I have questions about usage of Drizalma Sprinkle | Duloxetine Capsule, Delayed Release in breastfeeding?
US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday
UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700
Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week
Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week